Novel Biomarkers in Alzheimer’s Disease 

<br/><br/><br/>English[eng] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>flotillin||Alzheimer’s disease||biomarker||exosomes||beta-amyloid||Tau||aging||biomarkers||cytokines||cognitive decline||metabolomics||neuroinflammation||multivariate analysis||physical performance||person-tailored||PET/CT||(18F)FDG||neuropsychological assessment||APP mutations||APOE alleles||PSEN1||PSEN2||germline mutations||late onset AD||early onset AD||familial AD||genetics of AD||mitochondrial spare respiratory capacity||mitochondrial||membrane potential||glycolytic reserve||semantic memory||phonemic fluency||episodic memory||neuropsychology||neuroimaging||Alzheimer's disease||mild cognitive impairment||EEG||TMS||obesity||diabetes||inflammation||Amyloid Beta||mitochondrial dysfunction||nutrition||omega-3 fatty acids||antioxidant||carotenoids||vitamin E||cognition||older adults||ageing||subjective cognitive decline||clock genes||Clock||ApoE||cardiovascular risk factors||Alzheimer disease||semantic priming||amyloid beta||cerebrospinal fluid||amyloid beta peptide||total tau||phosphorylated tau||diagnosis||drug development||clinical trials||diagnostic research||virus||bacteria||dementia||blood||behavioral and psychological symptoms of dementia (BPSD)||Alzheimer’s disease (AD)||neuropsychiatry inventory scale (NPI)||endophenotypes||CART analysis||MTHFR||APOE||COMT||genetic variants||early diagnosis||biofluids||amyloid cascade hypothesis||glucose metabolism||adipose tissue dysfunction||energetic metabolism||lysosomes dysfunction||Type-3-Diabetes||neurodegeneration||amyloid||tau||soluble TREM2||NfL||Multiplex||SiMoA||diagnostics||messenger RNA||microRNA||neurotropic microbes||precision medicine||prognostics||synaptic biomarkers||neurofilament light chain||n/a